TrialLancet (London, England)2002

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial.

Heart Protection Study Collaborative GroupPubMed ↗Publisher ↗

No numbers read from the abstract.